Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 11, 2023 09:05 ET | Source: Palisade Bio, Inc.

Palisade Bio Announces Enrollment and Dosing of First Patient in LB1148 Dose Optimization Study

Study designed to determine if a different dosing protocol for all indications might enhance the risk profile of LB1148 while simultaneously providing efficacy Company expects enrollment to be...